BJDX CIK: 1704287

Bluejay Diagnostics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0.05
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.23
FY22:
−9.32
FY23:
−10.3
FY24:
−7.17
FY25:
−6.95
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−8.77
FY23:
−9.53
FY24:
−6.70
FY25:
−6.68
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−9.30
FY23:
−9.95
FY24:
−7.72
FY25:
−6.85
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.49
FY22:
−9.30
FY23:
−9.95
FY24:
−7.72
FY25:
−6.85

All amounts in millions USD Data sources:SEC EDGARTwelve Data